↓ Skip to main content

Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?

Overview of attention for article published in Gynecologic Oncology Research and Practice, March 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
34 Mendeley